Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA

NIP fet aneu Pnl Plas.cfDNA

Definition

Noninvasive prenatal testing for risk of fetal aneuploidy (e.g. trisomy 21, XXY, etc.) is performed using maternal plasma (or serum) which contains circulating cell free (ccf) DNA from the fetus. The probability and result interpretation (high risk/low risk) of aneuploidy are based on dosage ccf DNA from the mother and fetus as well as the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of trisomy 13, 18 and 21 as well as fetal sex chromosome aneuploidy in women with singleton pregnancies of at least 10 weeks gestational age.

Molecular pathology; MOLPATH; NIP fet aneu Pnl; NIPS; Non-invasive prenatal screening; Noninvasive prenatal testing; NPT; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random